USA — Bayer and Hologic have joined forces with a singular mission: to revolutionize breast cancer scans. Their visionary approach combines Bayer’s cutting-edge imaging contrast agents with Hologic’s state-of-the-art mammography…
Read MoreTag: Germany
BioNTech’s MPOX vaccine development gets financial boost of up to US$90 million
GERMANY — Germany’s pioneering biopharmaceutical company, BioNTech, has embarked on a transformative journey in the realm of infectious disease prevention, partnering with the Coalition for Epidemic Preparedness Innovations (CEPI). This…
Read MoreBayer’s new CEO sets sights on radical change to boost stock performance
GERMANY —Bayer’s newly appointed CEO, Bill Anderson, is planning a strategic overhaul that begins with trimming down management positions to expedite decision-making in a bold move aimed at rejuvenating the…
Read MoreRevolutionary cell therapy shows promise in Parkinson’s disease treatment
GERMANY — A groundbreaking cell therapy designed to combat Parkinson’s disease has achieved promising results in an early-stage clinical trial, as announced by its developer, Bluerock Therapeutics. The therapy, known…
Read MoreSiemens Healthineers faces cybersecurity challenge as LockBit ransomware group targets subsidiary
GERMANY — Siemens Healthineers, a key player in healthcare technology, is confronting a potential data breach as the LockBit ransomware group alleges an attack on one of its subsidiaries. The…
Read MoreBayer appoints Dr. Juergen Eckhardt as head of business development & licensing, leading a strategic push for external growth
GERMANY —In a strategic move poised to reshape the trajectory of its Pharmaceuticals Division, Bayer has named Dr. Juergen Eckhardt as the new Head of Business Development & Licensing /…
Read MoreBoehringer Ingelheim ventures into late-stage trials for innovative GLP-1-based drug
GERMANY — Boehringer Ingelheim, a pioneering pharmaceutical force, is intensifying its pursuit of an obesity drug contender, ready to challenge Novo Nordisk and Eli Lilly’s GLP-1 therapies. The company recently…
Read MoreGermany’s government approves ‘controlled’ cannabis usage for recreational purpose
GERMANY — Germany’s cabinet has ignited a heated debate by passing a landmark bill that paves the way for legalizing recreational marijuana use and cultivation. If approved by parliament, this…
Read MoreBayer’s turbulent path sees pharma sales slump drive earnings cut
GERMANY — Bayer, the prominent German pharmaceutical and pesticides manufacturer has revealed that its downward revision of this year’s earnings forecast was primarily influenced by a less optimistic outlook in…
Read MoreFresenius Kabi breaks new ground with EMA’s backing for its game-changing Tocilizumab biosimilar
GERMANY —Fresenius Kabi, a renowned global healthcare company specializing in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs, has achieved a major milestone with its tocilizumab biosimilar candidate MSB11456.…
Read More